Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Initial flow cytometric evaluation of the Clearllab lymphoid screen.

Cytometry. Part B, Clinical cytometry - 1 Sept 2018

Hedley B D, Cheng G, Luider J, Kern W, Lozanski G, Chin-Yee I, Lowes L E, Keeney M, Careaga D, Magari R, Tejidor L

Abstract excerpt

INTRODUCTION: Flow cytometric immunophenotyping (FCI) is an integral part in the diagnosis and classification of hematologic malignancies. FCI results also influence therapeutic decisions and disease prognosis. ClearLLab LS is a 12-antibody 10-color cocktail provided in dry format designed as a screen for patients suspected of having hematolymphoid disease. METHODS: A blinded comparison between ClearLLab LS,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma
Share to B-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to IVD gene

Share to Immunophenotyping

Share to Lymphoma

Share to Phenotype

Share to T-Lymphocytes

Source

Identifiers

PMID: 29171939
DOI: 10.1002/cyto.b.21603

Genes

APC
IVD
ECD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Initial flow cytometric evaluation of the Clearllab lymphoid screen.PMID 29171939Read ↗

Optimal number of reagents required to evaluate hematolymphoid neoplasias: Results of an international consensus meetingSemantic proximity Read ↗

Immunophenotyping of lymphoproliferative disorders: state of the art.Semantic proximity Read ↗

Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma.Semantic proximity Read ↗

Immunophenotypic Analysis of Hematogones (B-Lymphocyte Precursors) and Neoplastic Lymphoblasts by 4-Color Flow CytometrySemantic proximity Read ↗

Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathologySemantic proximity Read ↗

Diagnostic utility of the lymphoid screening tube supplemented with TRBC1 for the assessment of T‐cell clonalitySemantic proximity Read ↗

Challenging diagnosis in a patient with clear lymphoid immunohistochemical features and myeloid morphology: mixed phenotype acute leukemia with erythrophagocytosis.Semantic proximity Read ↗

How I Diagnose Minimal/Measurable Residual Disease in B Lymphoblastic Leukemia/Lymphoma by Flow CytometrySemantic proximity Read ↗

The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations.Semantic proximity Read ↗

Splenic lymphoid subsets with less well-recognized phenotypes mimic aberrant antigen expression.Semantic proximity Read ↗

Practical applications of immunohistochemistry in hematolymphoid neoplasms.Semantic proximity Read ↗

Lymphoid malignancies: immunophenotypic analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.